Mark Slater

Mark Slater is a seasoned professional with extensive experience in business development, international sales, commercial intelligence, market research, and competitive intelligence.

He currently serves as the Director of Business Development and International Sales at Britannia Pharmaceuticals Ltd, where he plays a pivotal role in driving growth and expanding the company's global presence.

Prior to his current role, Mark held the position of Associate Director of Business Development and Commercial Intelligence at Britannia Pharmaceuticals Ltd, showcasing his expertise in strategic planning and market analysis.

With a strong background in the pharmaceutical industry, Mark has held various key roles in renowned companies such as Norgine, Actis Sales Technologies, Cegedim, Organon Laboratories, and Roche, where he honed his skills in sales, market analysis, and client service.

His experience as the Global Competitive Intelligence Manager at Norgine highlights his proficiency in gathering and analyzing market data to enhance decision-making processes within the organization.

Mark's tenure as the Head of Analytical Services at Actis Sales Technologies further demonstrates his leadership abilities and strategic vision in driving business success.

His role as a Client Service Manager at Cegedim allowed him to develop strong relationships with clients and deliver exceptional service, contributing to long-term business growth and customer satisfaction.

Mark Slater's diverse experience in roles such as Senior Business Intelligence Executive at Organon Laboratories, Sales Representative at Roche, Market Analyst at Roche Products, and Drug Safety Associate at Roche Pharmaceuticals underscores his versatile skill set and deep understanding of the pharmaceutical sector.

Overall, Mark Slater is a results-driven professional with a proven track record of success in business development, sales, market research, and competitive intelligence across various prestigious organizations.